Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i<
Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe ty...
Ausführliche Beschreibung
Autor*in: |
EunJin Bang [verfasserIn] Sang-Gyun Noh [verfasserIn] Sugyeong Ha [verfasserIn] Hee Jin Jung [verfasserIn] Dae Hyun Kim [verfasserIn] A Kyoung Lee [verfasserIn] Min Kyung Hyun [verfasserIn] Dongwan Kang [verfasserIn] Sanggwon Lee [verfasserIn] Chaeun Park [verfasserIn] Hyung Ryong Moon [verfasserIn] Hae Young Chung [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2018 |
---|
Schlagwörter: |
---|
Übergeordnetes Werk: |
In: Molecules - MDPI AG, 2003, 23(2018), 12, p 3307 |
---|---|
Übergeordnetes Werk: |
volume:23 ; year:2018 ; number:12, p 3307 |
Links: |
---|
DOI / URN: |
10.3390/molecules23123307 |
---|
Katalog-ID: |
DOAJ040036685 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ040036685 | ||
003 | DE-627 | ||
005 | 20230308033632.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/molecules23123307 |2 doi | |
035 | |a (DE-627)DOAJ040036685 | ||
035 | |a (DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a QD241-441 | |
100 | 0 | |a EunJin Bang |e verfasserin |4 aut | |
245 | 1 | 0 | |a Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< |
264 | 1 | |c 2018 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. | ||
650 | 4 | |a (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one | |
650 | 4 | |a tyrosinase | |
650 | 4 | |a <i<in silico</i< docking simulation | |
650 | 4 | |a B16F10 | |
650 | 4 | |a α-melanocyte-stimulating hormone | |
653 | 0 | |a Organic chemistry | |
700 | 0 | |a Sang-Gyun Noh |e verfasserin |4 aut | |
700 | 0 | |a Sugyeong Ha |e verfasserin |4 aut | |
700 | 0 | |a Hee Jin Jung |e verfasserin |4 aut | |
700 | 0 | |a Dae Hyun Kim |e verfasserin |4 aut | |
700 | 0 | |a A Kyoung Lee |e verfasserin |4 aut | |
700 | 0 | |a Min Kyung Hyun |e verfasserin |4 aut | |
700 | 0 | |a Dongwan Kang |e verfasserin |4 aut | |
700 | 0 | |a Sanggwon Lee |e verfasserin |4 aut | |
700 | 0 | |a Chaeun Park |e verfasserin |4 aut | |
700 | 0 | |a Hyung Ryong Moon |e verfasserin |4 aut | |
700 | 0 | |a Hae Young Chung |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Molecules |d MDPI AG, 2003 |g 23(2018), 12, p 3307 |w (DE-627)311313132 |w (DE-600)2008644-1 |x 14203049 |7 nnns |
773 | 1 | 8 | |g volume:23 |g year:2018 |g number:12, p 3307 |
856 | 4 | 0 | |u https://doi.org/10.3390/molecules23123307 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf |z kostenfrei |
856 | 4 | 0 | |u https://www.mdpi.com/1420-3049/23/12/3307 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/1420-3049 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_70 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_224 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
951 | |a AR | ||
952 | |d 23 |j 2018 |e 12, p 3307 |
author_variant |
e b eb s g n sgn s h sh h j j hjj d h k dhk a k l akl m k h mkh d k dk s l sl c p cp h r m hrm h y c hyc |
---|---|
matchkey_str |
article:14203049:2018----::vlainfhnvlyteitrsnsihbtrz3boohdoyezldnticrmno |
hierarchy_sort_str |
2018 |
callnumber-subject-code |
QD |
publishDate |
2018 |
allfields |
10.3390/molecules23123307 doi (DE-627)DOAJ040036685 (DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf DE-627 ger DE-627 rakwb eng QD241-441 EunJin Bang verfasserin aut Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one tyrosinase <i<in silico</i< docking simulation B16F10 α-melanocyte-stimulating hormone Organic chemistry Sang-Gyun Noh verfasserin aut Sugyeong Ha verfasserin aut Hee Jin Jung verfasserin aut Dae Hyun Kim verfasserin aut A Kyoung Lee verfasserin aut Min Kyung Hyun verfasserin aut Dongwan Kang verfasserin aut Sanggwon Lee verfasserin aut Chaeun Park verfasserin aut Hyung Ryong Moon verfasserin aut Hae Young Chung verfasserin aut In Molecules MDPI AG, 2003 23(2018), 12, p 3307 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:23 year:2018 number:12, p 3307 https://doi.org/10.3390/molecules23123307 kostenfrei https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf kostenfrei https://www.mdpi.com/1420-3049/23/12/3307 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 23 2018 12, p 3307 |
spelling |
10.3390/molecules23123307 doi (DE-627)DOAJ040036685 (DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf DE-627 ger DE-627 rakwb eng QD241-441 EunJin Bang verfasserin aut Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one tyrosinase <i<in silico</i< docking simulation B16F10 α-melanocyte-stimulating hormone Organic chemistry Sang-Gyun Noh verfasserin aut Sugyeong Ha verfasserin aut Hee Jin Jung verfasserin aut Dae Hyun Kim verfasserin aut A Kyoung Lee verfasserin aut Min Kyung Hyun verfasserin aut Dongwan Kang verfasserin aut Sanggwon Lee verfasserin aut Chaeun Park verfasserin aut Hyung Ryong Moon verfasserin aut Hae Young Chung verfasserin aut In Molecules MDPI AG, 2003 23(2018), 12, p 3307 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:23 year:2018 number:12, p 3307 https://doi.org/10.3390/molecules23123307 kostenfrei https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf kostenfrei https://www.mdpi.com/1420-3049/23/12/3307 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 23 2018 12, p 3307 |
allfields_unstemmed |
10.3390/molecules23123307 doi (DE-627)DOAJ040036685 (DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf DE-627 ger DE-627 rakwb eng QD241-441 EunJin Bang verfasserin aut Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one tyrosinase <i<in silico</i< docking simulation B16F10 α-melanocyte-stimulating hormone Organic chemistry Sang-Gyun Noh verfasserin aut Sugyeong Ha verfasserin aut Hee Jin Jung verfasserin aut Dae Hyun Kim verfasserin aut A Kyoung Lee verfasserin aut Min Kyung Hyun verfasserin aut Dongwan Kang verfasserin aut Sanggwon Lee verfasserin aut Chaeun Park verfasserin aut Hyung Ryong Moon verfasserin aut Hae Young Chung verfasserin aut In Molecules MDPI AG, 2003 23(2018), 12, p 3307 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:23 year:2018 number:12, p 3307 https://doi.org/10.3390/molecules23123307 kostenfrei https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf kostenfrei https://www.mdpi.com/1420-3049/23/12/3307 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 23 2018 12, p 3307 |
allfieldsGer |
10.3390/molecules23123307 doi (DE-627)DOAJ040036685 (DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf DE-627 ger DE-627 rakwb eng QD241-441 EunJin Bang verfasserin aut Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one tyrosinase <i<in silico</i< docking simulation B16F10 α-melanocyte-stimulating hormone Organic chemistry Sang-Gyun Noh verfasserin aut Sugyeong Ha verfasserin aut Hee Jin Jung verfasserin aut Dae Hyun Kim verfasserin aut A Kyoung Lee verfasserin aut Min Kyung Hyun verfasserin aut Dongwan Kang verfasserin aut Sanggwon Lee verfasserin aut Chaeun Park verfasserin aut Hyung Ryong Moon verfasserin aut Hae Young Chung verfasserin aut In Molecules MDPI AG, 2003 23(2018), 12, p 3307 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:23 year:2018 number:12, p 3307 https://doi.org/10.3390/molecules23123307 kostenfrei https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf kostenfrei https://www.mdpi.com/1420-3049/23/12/3307 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 23 2018 12, p 3307 |
allfieldsSound |
10.3390/molecules23123307 doi (DE-627)DOAJ040036685 (DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf DE-627 ger DE-627 rakwb eng QD241-441 EunJin Bang verfasserin aut Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< 2018 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one tyrosinase <i<in silico</i< docking simulation B16F10 α-melanocyte-stimulating hormone Organic chemistry Sang-Gyun Noh verfasserin aut Sugyeong Ha verfasserin aut Hee Jin Jung verfasserin aut Dae Hyun Kim verfasserin aut A Kyoung Lee verfasserin aut Min Kyung Hyun verfasserin aut Dongwan Kang verfasserin aut Sanggwon Lee verfasserin aut Chaeun Park verfasserin aut Hyung Ryong Moon verfasserin aut Hae Young Chung verfasserin aut In Molecules MDPI AG, 2003 23(2018), 12, p 3307 (DE-627)311313132 (DE-600)2008644-1 14203049 nnns volume:23 year:2018 number:12, p 3307 https://doi.org/10.3390/molecules23123307 kostenfrei https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf kostenfrei https://www.mdpi.com/1420-3049/23/12/3307 kostenfrei https://doaj.org/toc/1420-3049 Journal toc kostenfrei GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 AR 23 2018 12, p 3307 |
language |
English |
source |
In Molecules 23(2018), 12, p 3307 volume:23 year:2018 number:12, p 3307 |
sourceStr |
In Molecules 23(2018), 12, p 3307 volume:23 year:2018 number:12, p 3307 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
(<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one tyrosinase <i<in silico</i< docking simulation B16F10 α-melanocyte-stimulating hormone Organic chemistry |
isfreeaccess_bool |
true |
container_title |
Molecules |
authorswithroles_txt_mv |
EunJin Bang @@aut@@ Sang-Gyun Noh @@aut@@ Sugyeong Ha @@aut@@ Hee Jin Jung @@aut@@ Dae Hyun Kim @@aut@@ A Kyoung Lee @@aut@@ Min Kyung Hyun @@aut@@ Dongwan Kang @@aut@@ Sanggwon Lee @@aut@@ Chaeun Park @@aut@@ Hyung Ryong Moon @@aut@@ Hae Young Chung @@aut@@ |
publishDateDaySort_date |
2018-01-01T00:00:00Z |
hierarchy_top_id |
311313132 |
id |
DOAJ040036685 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ040036685</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308033632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/molecules23123307</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ040036685</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QD241-441</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">EunJin Bang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i<</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">(<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tyrosinase</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<in silico</i< docking simulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">B16F10</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">α-melanocyte-stimulating hormone</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Organic chemistry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sang-Gyun Noh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sugyeong Ha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hee Jin Jung</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dae Hyun Kim</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A Kyoung Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Min Kyung Hyun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dongwan Kang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sanggwon Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Chaeun Park</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hyung Ryong Moon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hae Young Chung</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Molecules</subfield><subfield code="d">MDPI AG, 2003</subfield><subfield code="g">23(2018), 12, p 3307</subfield><subfield code="w">(DE-627)311313132</subfield><subfield code="w">(DE-600)2008644-1</subfield><subfield code="x">14203049</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:12, p 3307</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/molecules23123307</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/1420-3049/23/12/3307</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1420-3049</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2018</subfield><subfield code="e">12, p 3307</subfield></datafield></record></collection>
|
callnumber-first |
Q - Science |
author |
EunJin Bang |
spellingShingle |
EunJin Bang misc QD241-441 misc (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one misc tyrosinase misc <i<in silico</i< docking simulation misc B16F10 misc α-melanocyte-stimulating hormone misc Organic chemistry Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< |
authorStr |
EunJin Bang |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)311313132 |
format |
electronic Article |
delete_txt_mv |
keep |
author_role |
aut aut aut aut aut aut aut aut aut aut aut aut |
collection |
DOAJ |
remote_str |
true |
callnumber-label |
QD241-441 |
illustrated |
Not Illustrated |
issn |
14203049 |
topic_title |
QD241-441 Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one tyrosinase <i<in silico</i< docking simulation B16F10 α-melanocyte-stimulating hormone |
topic |
misc QD241-441 misc (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one misc tyrosinase misc <i<in silico</i< docking simulation misc B16F10 misc α-melanocyte-stimulating hormone misc Organic chemistry |
topic_unstemmed |
misc QD241-441 misc (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one misc tyrosinase misc <i<in silico</i< docking simulation misc B16F10 misc α-melanocyte-stimulating hormone misc Organic chemistry |
topic_browse |
misc QD241-441 misc (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one misc tyrosinase misc <i<in silico</i< docking simulation misc B16F10 misc α-melanocyte-stimulating hormone misc Organic chemistry |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
hierarchy_parent_title |
Molecules |
hierarchy_parent_id |
311313132 |
hierarchy_top_title |
Molecules |
isfreeaccess_txt |
true |
familylinks_str_mv |
(DE-627)311313132 (DE-600)2008644-1 |
title |
Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< |
ctrlnum |
(DE-627)DOAJ040036685 (DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf |
title_full |
Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< |
author_sort |
EunJin Bang |
journal |
Molecules |
journalStr |
Molecules |
callnumber-first-code |
Q |
lang_code |
eng |
isOA_bool |
true |
recordtype |
marc |
publishDateSort |
2018 |
contenttype_str_mv |
txt |
author_browse |
EunJin Bang Sang-Gyun Noh Sugyeong Ha Hee Jin Jung Dae Hyun Kim A Kyoung Lee Min Kyung Hyun Dongwan Kang Sanggwon Lee Chaeun Park Hyung Ryong Moon Hae Young Chung |
container_volume |
23 |
class |
QD241-441 |
format_se |
Elektronische Aufsätze |
author-letter |
EunJin Bang |
doi_str_mv |
10.3390/molecules23123307 |
author2-role |
verfasserin |
title_sort |
evaluation of the novel synthetic tyrosinase inhibitor (<i<z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (mhy1498) <i<in vitro</i< and <i<in silico</i< |
callnumber |
QD241-441 |
title_auth |
Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< |
abstract |
Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. |
abstractGer |
Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. |
abstract_unstemmed |
Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders. |
collection_details |
GBV_USEFLAG_A SYSFLAG_A GBV_DOAJ GBV_ILN_20 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_39 GBV_ILN_40 GBV_ILN_60 GBV_ILN_62 GBV_ILN_63 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_73 GBV_ILN_95 GBV_ILN_105 GBV_ILN_110 GBV_ILN_151 GBV_ILN_161 GBV_ILN_170 GBV_ILN_206 GBV_ILN_213 GBV_ILN_224 GBV_ILN_230 GBV_ILN_285 GBV_ILN_293 GBV_ILN_602 GBV_ILN_2005 GBV_ILN_2009 GBV_ILN_2011 GBV_ILN_2014 GBV_ILN_2055 GBV_ILN_2111 GBV_ILN_4012 GBV_ILN_4037 GBV_ILN_4112 GBV_ILN_4125 GBV_ILN_4126 GBV_ILN_4249 GBV_ILN_4305 GBV_ILN_4306 GBV_ILN_4307 GBV_ILN_4313 GBV_ILN_4322 GBV_ILN_4323 GBV_ILN_4324 GBV_ILN_4325 GBV_ILN_4338 GBV_ILN_4367 GBV_ILN_4700 |
container_issue |
12, p 3307 |
title_short |
Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i< |
url |
https://doi.org/10.3390/molecules23123307 https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf https://www.mdpi.com/1420-3049/23/12/3307 https://doaj.org/toc/1420-3049 |
remote_bool |
true |
author2 |
Sang-Gyun Noh Sugyeong Ha Hee Jin Jung Dae Hyun Kim A Kyoung Lee Min Kyung Hyun Dongwan Kang Sanggwon Lee Chaeun Park Hyung Ryong Moon Hae Young Chung |
author2Str |
Sang-Gyun Noh Sugyeong Ha Hee Jin Jung Dae Hyun Kim A Kyoung Lee Min Kyung Hyun Dongwan Kang Sanggwon Lee Chaeun Park Hyung Ryong Moon Hae Young Chung |
ppnlink |
311313132 |
callnumber-subject |
QD - Chemistry |
mediatype_str_mv |
c |
isOA_txt |
true |
hochschulschrift_bool |
false |
doi_str |
10.3390/molecules23123307 |
callnumber-a |
QD241-441 |
up_date |
2024-07-04T01:42:13.628Z |
_version_ |
1803610838668410880 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">DOAJ040036685</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230308033632.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">230227s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3390/molecules23123307</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)DOAJ040036685</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DOAJbe8cf39cd9dc4f9e811f15d943447dbf</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QD241-441</subfield></datafield><datafield tag="100" ind1="0" ind2=" "><subfield code="a">EunJin Bang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Evaluation of the Novel Synthetic Tyrosinase Inhibitor (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498) <i<In Vitro</i< and <i<In Silico</i<</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tyrosinase is a key enzyme in melanin synthesis, catalyzing the initial rate-limiting steps of melanin synthesis. Abnormal and excessive melanin synthesis is the primary cause of serious skin disorders including melasma, senile lentigo, freckles, and age spots. In attempts to find potent and safe tyrosinase inhibitors, we designed and synthesized a novel compound, (<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one (MHY1498), and evaluated its tyrosinase inhibitory activity <i<in vitro</i< and <i<in silico</i<. The chemical structures of (<i<Z</i<)-3-benzylidenethiochroman-4-one analogues, including the novel compound MHY1498, were rationally designed and synthesized as hybrid structures of reported potent tyrosinase inhibitors, which were confirmed both <i<in vitro</i< and <i<in vivo</i<: (<i<Z</i<)-5-(substituted benzylidene)thiazolidine-2,4-diones (Compound A) and 2-(substituted phenyl)benzo[<i<d</i<]thiazoles (Compound B). During screening, MHY1498 showed a strong dose-dependent inhibitory effect on mushroom tyrosinase. The IC<sub<50</sub< value of MHY1498 (4.1 ± 0.6 μM) was significantly lower than that of the positive control, kojic acid (22.0 ± 4.7 μM). <i<In silico</i< molecular multi-docking simulation and inhibition mechanism studies indicated that MHY1498 interacts competitively with the tyrosinase enzyme, with greater affinity for the active site of tyrosinase than the positive control. Furthermore, in B16F10 melanoma cells treated with α-melanocyte-stimulating hormone, MHY1498 suppressed both melanin production and tyrosinase activity. In conclusion, our data demonstrate that MHY1498, a synthesized novel compound, effectively inhibits tyrosinase activity and has potential for treating hyperpigmentation and related disorders.</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">(<i<Z</i<)-3-(3-bromo-4-hydroxybenzylidene)thiochroman-4-one</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">tyrosinase</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a"><i<in silico</i< docking simulation</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">B16F10</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">α-melanocyte-stimulating hormone</subfield></datafield><datafield tag="653" ind1=" " ind2="0"><subfield code="a">Organic chemistry</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sang-Gyun Noh</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sugyeong Ha</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hee Jin Jung</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dae Hyun Kim</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">A Kyoung Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Min Kyung Hyun</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Dongwan Kang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Sanggwon Lee</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Chaeun Park</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hyung Ryong Moon</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Hae Young Chung</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Molecules</subfield><subfield code="d">MDPI AG, 2003</subfield><subfield code="g">23(2018), 12, p 3307</subfield><subfield code="w">(DE-627)311313132</subfield><subfield code="w">(DE-600)2008644-1</subfield><subfield code="x">14203049</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2018</subfield><subfield code="g">number:12, p 3307</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3390/molecules23123307</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doaj.org/article/be8cf39cd9dc4f9e811f15d943447dbf</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://www.mdpi.com/1420-3049/23/12/3307</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="u">https://doaj.org/toc/1420-3049</subfield><subfield code="y">Journal toc</subfield><subfield code="z">kostenfrei</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_DOAJ</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_39</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_62</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_63</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_95</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_110</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_151</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_161</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_206</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_213</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_224</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_230</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_285</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_293</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_602</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2011</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2055</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4037</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4112</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4125</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4126</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4249</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4305</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4306</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4307</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4313</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4322</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4323</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4324</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4325</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4338</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4367</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_4700</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2018</subfield><subfield code="e">12, p 3307</subfield></datafield></record></collection>
|
score |
7.398694 |